Axsome Therapeutics AXSM
NASDAQ AXSM
$183.65 -0.74 (-0.40%)
As of: Oct 1, 2026 · 12:39 PM EDT

Axsome Therapeutics (AXSM) Total Non-Current Liabilities (2017 - 2026)

Updated

Axsome Therapeutics (AXSM) posted Total Non-Current Liabilities of $609.01 million for Q2 2026, up 25.0% from $487.06 million a year earlier and up 4.1% from the prior quarter.

Analysis

Axsome Therapeutics (AXSM) Total Non-Current Liabilities (2017 - 2026) Analysis & Trends

At the end of FY2025, Axsome Therapeutics' Total Non-Current Liabilities came in at $523.97 million, up 24.8% from FY2024.

  • Annual Total Non-Current Liabilities has increased for three consecutive years, with a three-year compound annual growth rate of 40.0% (FY2022 to FY2025).
  • In prior years, Axsome Therapeutics' Total Non-Current Liabilities was $419.8 million in FY2024 (+29.6%), $323.96 million in FY2023 (+69.8%) and $190.82 million in FY2022.
  • The Q2 2026 figure stands as the highest quarterly Total Non-Current Liabilities in data going back to Q4 2017.
  • On a year-over-year basis, Total Non-Current Liabilities has increased in each of the last 13 quarters, with growth averaging 29.3% over the last eight quarters.
  • The year-over-year growth in Total Non-Current Liabilities has ranged between 24.8% (Q4 2025) and 120.1% (Q2 2023) over the last five years.
  • According to Business Quant data, Total Non-Current Liabilities for the three prior quarters was $585.29 million (Q1 2026), $523.97 million (Q4 2025) and $505.65 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 105.99 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 106.45 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -967.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 36.04 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 5.92 Bn
10 Axsome Therapeutics 9.64 Bn 8.37 Bn 204.81 Mn 609.01 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 609.01 Mn
Mar 31, 2026 585.29 Mn
Dec 31, 2025 523.97 Mn
Sep 30, 2025 505.65 Mn
Jun 30, 2025 487.06 Mn
Mar 31, 2025 452.88 Mn
Dec 31, 2024 419.80 Mn
Sep 30, 2024 385.58 Mn
Jun 30, 2024 375.75 Mn
Mar 31, 2024 331.69 Mn
Dec 31, 2023 323.96 Mn
Sep 30, 2023 299.80 Mn
Jun 30, 2023 299.33 Mn
Mar 31, 2023 248.27 Mn
Dec 31, 2022 190.82 Mn
Sep 30, 2022 154.20 Mn
Jun 30, 2022 136.03 Mn
Sep 30, 2018 15.28 Mn
Jun 30, 2018 14.60 Mn
Mar 31, 2018 15.24 Mn
API Access

Axsome Therapeutics Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=AXSM&period=max&api_key=YOUR_API_KEY